?
Læs mere om arbejdspladslogin her.

Content area

Videnskab / 11. sep 2017
Malignt melanom. (Foto: Georg Authried, Dermatologisk Afdeling, Odense Universitetshospital).

Akut induceret diabetes mellitus hos en patient i behandling for metastaserende malignt melanom

Kasuistik
Dato
11. sep 2017
Forfattere
Line Bisgaard Jørgensen & Knud Yderstræde Endokrinologisk Afdeling M, Odense Universitetshospital Ugeskr Læger 2017;179:V03170188
💬 0
Reference: 
Ugeskr Læger 2017;179:V03170188
Sidetal: 
2-3
Acutely induced diabetes mellitus in a 63-year-old female after treatment with ipilimumab for metastatic melanoma
Immune checkpoint inhibitors have improved survival rate in patients with advanced melanoma, but also have the potential to induce several adverse events. We report on a 63-year-old woman who had advanced melanoma and was admitted with diabetic ketoacidosis, which had occurred upon treatment with ipilimumab. On admission, the C-peptide level was low, and the HbA1c concentration was 50 mmol/l indicating a rapid onset of the disease. The patient had also been diagnosed with thyroiditis. Diabetes mellitus is a rare and serious side effect of treatment with ipilimumab, and we recommend being aware of this due to the rapid course.

💬 0 Kommentarer

Du skal være logget ind for at læse denne artikel
Log ind

Du kan også købe adgang

Køb abonnement til Ugeskriftet.dk (der er forskellige abonnementstyper )

Right side

Nr. 23/2017

Senest kommenteret

Jørgen vil dø
💬
1
Benedicte Vibjerg Wilson 23. nov 2017 15:10
Læger på delt tid skal holde liv i udkantssygehus
💬
1
Nanna Døssing 22. nov 2017 23:04
Man bliver heller ikke klogere af misinformation…
💬
8
Mats Lindberg 22. nov 2017 22:40
Når journaler bliver afkrydsningsskemaer
💬
9
Mogens Stubkjær Hüttel 21. nov 2017 08:55

Nyeste debat